Acumen Pharmaceuticals, Inc. Common Stock (ABOS)

Typically moves ±6.71% on earnings

EARNINGS ANALYTICS

event_upcoming Est. Next Earnings: 2026-11-12 ESTIMATED

Across 21 earnings reports since Aug 16, 2021, Acumen Pharmaceuticals, Inc. Common Stock (ABOS) has a clear post-earnings pattern. It moves ±6.71% on average after reporting and finishes higher 61.9% of the time. Its largest post-earnings gain was +17.3% (May 09, 2023) and its largest decline was -17.03% (Nov 12, 2024). The next earnings report is predicted for 2026-11-12 (estimated).

Earnings reactions

How ABOS moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

Avg Abs. Movement

±6.71%

Positive %

61.9%

Negative %

38.1%

Historical Earnings Statistics

Date	Timing	Earnings move	SEC Filing
Aug 12, 2026	☀ PRE	+1.21%	open_in_new
May 12, 2026	☀ PRE	-3.5%	open_in_new
Mar 26, 2026	☀ PRE	-2.3%	open_in_new
Nov 12, 2025	☀ PRE	-1.02%	open_in_new
Aug 12, 2025	☀ PRE	-10.64%	open_in_new
May 13, 2025	☀ PRE	+0%	open_in_new
Mar 27, 2025	☀ PRE	+6.96%	open_in_new
Nov 12, 2024	☀ PRE	-17.03%	open_in_new
Aug 13, 2024	☀ PRE	+8.2%	open_in_new
May 14, 2024	☀ PRE	+10.3%	open_in_new
Mar 26, 2024	☀ PRE	-11.85%	open_in_new
Nov 13, 2023	☀ PRE	+6.28%	open_in_new
Aug 08, 2023	☀ PRE	+0.29%	open_in_new
May 09, 2023	☀ PRE	+17.3%	open_in_new
Mar 27, 2023	☀ PRE	+6.24%	open_in_new
Nov 14, 2022	☽ POST	+3.57%	open_in_new
Aug 15, 2022	☽ POST	+5.91%	open_in_new
May 16, 2022	☽ POST	+12.69%	open_in_new
Mar 28, 2022	☽ POST	-5.07%	open_in_new
Nov 15, 2021	☀ PRE	-9.58%	open_in_new
Aug 16, 2021	☽ POST	+0.92%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±6.71%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 21 →

Funds holding

$18365834

Total value held

Buying

13 added · 4 reduced

Blackrock, Inc.

$6648607 +1296.38%

Franklin Resources Inc

$6154606 Held

State Street Corp

$1603410 +295.79%

Northern Trust Corp

$963187 +379.64%

Bank Of America Corp /De/

$733665 -14.19%

SEC Filing Types

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
10-Q	20260812	open_in_new SEC.gov
8-K	20260812	open_in_new SEC.gov
S-8	20260812	open_in_new SEC.gov
144	20260617	open_in_new SEC.gov
4	20260617	open_in_new SEC.gov
144	20260616	open_in_new SEC.gov
8-K	20260616	open_in_new SEC.gov
144	20260615	open_in_new SEC.gov
4	20260610	open_in_new SEC.gov
144	20260609	open_in_new SEC.gov

Frequently asked about ABOS earnings

When does Acumen Pharmaceuticals, Inc. Common Stock report earnings next? expand_more

Acumen Pharmaceuticals, Inc. Common Stock (ABOS)'s next earnings date is estimated for 2026-11-12. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does ABOS stock move after earnings? expand_more

Over 21 reports, ABOS has moved an average of ±6.71% the session after earnings, closing higher 61.9% of the time.

What was ABOS's biggest post-earnings move? expand_more

ABOS's largest post-earnings gain on record was +17.3% on May 09, 2023, and its largest decline was -17.03% on Nov 12, 2024.

Where can I find Acumen Pharmaceuticals, Inc. Common Stock's SEC filings? expand_more

All of Acumen Pharmaceuticals, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.